Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 13, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, August 10, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Gary Nachman Maintained (AMRX) at Hold with Increased Target to $20 on, Aug 10th, 2018
Gary Nachman of BMO Capital, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Hold with Increased Target from $19 to $20 on, Aug 10th, 2018.
Gary has made no other calls on AMRX in the last 4 months.
There are 2 other peers that have a rating on AMRX. Out of the 2 peers that are also analyzing AMRX, 0 agree with Gary's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Gary
- David Risinger of "Morgan Stanley" Initiated at Buy and Held Target at $22 on, Monday, July 23rd, 2018
- David Buck of "B. Riley Securities" Initiated at Strong Buy and Held Target at $26 on, Friday, June 22nd, 2018
